Rx drug information, pharmaceutical research, clinical trials, news, and more
HETLIOZ (tasimelteon) is a melatonin receptor agonist.
HETLIOZ is indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24).
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. [2009]associated with shifted sleep and wake time... INTERPRETATION: After an abrupt advance in sleep time, tasimelteon improved sleep
Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder. [2014]CONCLUSION: Tasimelteon improves sleep initiation and maintenance in patients
All Rights reserved - Copyright DrugLib.com, 2006-2017